What is a stock summary page? Click here for an overview.
Business Description
Spire Healthcare Group PLC
ISIN : GB00BNLPYF73
Compare
Compare
Traded in other countries / regions
SPI.UKS00.Germany IPO Date
2008-11-07Description
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital that has delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs, and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.71 | |||||
Debt-to-EBITDA | 5.14 | |||||
Interest Coverage | 1.27 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.77 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10 | |||||
3-Year EBITDA Growth Rate | 9.8 | |||||
3-Year FCF Growth Rate | 1.6 | |||||
3-Year Book Growth Rate | 1.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 35.91 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.75 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.47 | |||||
9-Day RSI | 25.01 | |||||
14-Day RSI | 24.15 | |||||
3-1 Month Momentum % | 1 | |||||
6-1 Month Momentum % | -3.82 | |||||
12-1 Month Momentum % | -2.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.66 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 20.05 | |||||
Days Sales Outstanding | 19.27 | |||||
Days Payable | 32.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.22 | |||||
Dividend Payout Ratio | 0.24 | |||||
Forward Dividend Yield % | 1.34 | |||||
5-Year Yield-on-Cost % | 1.22 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -3.24 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 45.24 | |||||
Operating Margin % | 8.27 | |||||
Net Margin % | 1.68 | |||||
FCF Margin % | 8.18 | |||||
ROE % | 3.42 | |||||
ROA % | 1.1 | |||||
ROIC % | 3.72 | |||||
3-Year ROIIC % | -91.94 | |||||
ROC (Joel Greenblatt) % | 8.38 | |||||
ROCE % | 6.9 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 27.72 | |||||
Forward PE Ratio | 15.76 | |||||
PE Ratio without NRI | 19.98 | |||||
Price-to-Owner-Earnings | 14.37 | |||||
PS Ratio | 0.46 | |||||
PB Ratio | 0.92 | |||||
Price-to-Tangible-Book | 2.23 | |||||
Price-to-Free-Cash-Flow | 5.71 | |||||
Price-to-Operating-Cash-Flow | 3.01 | |||||
EV-to-EBIT | 14.09 | |||||
EV-to-Forward-EBIT | 10.61 | |||||
EV-to-EBITDA | 7.74 | |||||
EV-to-Forward-EBITDA | 6.62 | |||||
EV-to-Revenue | 1.26 | |||||
EV-to-Forward-Revenue | 1.2 | |||||
EV-to-FCF | 15.74 | |||||
Price-to-GF-Value | 0.6 | |||||
Price-to-Projected-FCF | 0.38 | |||||
Price-to-Median-PS-Value | 0.57 | |||||
Price-to-Graham-Number | 1.41 | |||||
Earnings Yield (Greenblatt) % | 7.1 | |||||
FCF Yield % | 17.86 | |||||
Forward Rate of Return (Yacktman) % | 12.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spire Healthcare Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 1,511.2 | ||
EPS (TTM) (£) | 0.062 | ||
Beta | 1.03 | ||
3-Year Sharpe Ratio | -0.11 | ||
3-Year Sortino Ratio | -0.14 | ||
Volatility % | 21 | ||
14-Day RSI | 24.15 | ||
14-Day ATR (£) | 0.051666 | ||
20-Day SMA (£) | 1.86135 | ||
12-1 Month Momentum % | -2.48 | ||
52-Week Range (£) | 1.688 - 2.705 | ||
Shares Outstanding (Mil) | 402.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Spire Healthcare Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Spire Healthcare Group PLC Stock Events
Event | Date | Price (£) | ||
---|---|---|---|---|
No Event Data |
Spire Healthcare Group PLC Frequently Asked Questions
What is Spire Healthcare Group PLC(CHIX:SPIl)'s stock price today?
The current price of CHIX:SPIl is £1.72. The 52 week high of CHIX:SPIl is £2.71 and 52 week low is £1.69.
When is next earnings date of Spire Healthcare Group PLC(CHIX:SPIl)?
The next earnings date of Spire Healthcare Group PLC(CHIX:SPIl) is 2025-09-11.
Does Spire Healthcare Group PLC(CHIX:SPIl) pay dividends? If so, how much?
The Dividend Yield %  of Spire Healthcare Group PLC(CHIX:SPIl) is 1.22% (As of Today), Highest Dividend Payout Ratio of Spire Healthcare Group PLC(CHIX:SPIl) was 1.58. The lowest was 0.07. And the median was 0.24. The  Forward Dividend Yield % of Spire Healthcare Group PLC(CHIX:SPIl) is 1.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |